MIH
VIVE

Meitav Investment House’s VIVEVE MED INC VIVE Stock Holding History

Meitav Investment House’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-60,000
Closed -$137K – 428
2021
Q3 		$137K Hold
60,000
– – ﹤0.01% 389
2021
Q2 		$178K Buy
60,000
+5,000
+9% +$14.1K ﹤0.01% 393
2021
Q1 		$168 Buy
+55,000
New +$202K ﹤0.01% 365
2019
Q3 		– Sell
-918
Closed -$352K – 485
2019
Q2 		$352K Sell
918
-71
-7% -$38.5K 0.02% 310
2019
Q1 		$955K Buy
989
+229
+30% +$243K 0.05% 177
2018
Q4 		$794K Buy
760
+250
+49% +$600K 0.05% 169
2018
Q3 		$1.35M Buy
510
+200
+65% +$567K 0.07% 174
2018
Q2 		$800K Buy
+310
New +$893K 0.04% 257

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Meitav Investment House's VIVE Position: Q4 2021 in Review

Meitav Investment House sold out of VIVEVE MED INC (VIVE) in Q4 2021, closing a stake of 60,000 shares — an estimated $137K sold.

Meitav Investment House first reported a position in VIVE in Q2 2018 and held it in 8 quarters. The position peaked at $1.35M in Q3 2018. 19 funds tracked by Wall St. Rank hold VIVE as of Q4 2021.

  • Meitav Investment House reported no remaining VIVEVE MED INC position as of Q4 2021 after selling out during the quarter.
  • Meitav Investment House sold 60,000 VIVEVE MED INC shares in Q4 2021, an estimated $137K.
  • Meitav Investment House first reported a position in VIVEVE MED INC in Q2 2018 and held it in 8 quarters.
  • Meitav Investment House's VIVEVE MED INC position peaked at $1.35M in Q3 2018.
  • 19 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2021.

Based on Meitav Investment House's 13F filing for Q4 2021, filed 8 Feb 2022.